medigraphic.com
ISSN 1561-3186 (Electronic)

2021, Number 1

<< Back

Rev Acta Médica 2021; 22 (1)

Hospital surveillance against COVID-19 at the Institute of Nephology in the period from march to june 2020

Fiterre LI, Simón FD, Bohorques RR, García VY, Fernández SVS, Pérez ODJF, Guerra BGJ

Language: Spanish
References: 18
Page:
PDF size: 86.57 Kb.


ABSTRACT

Objective: Prove the outcome of the COVID 19 surveillance system.
Methods: A prospective observational study on COVID-19 surveillance at the Institute of Nephrology from March to June 2020 with the implementation of a surveillance system and the institutional Protocol. The information was processed in an Excel spreadsheet; the absolute and relative frequencies were determined, the information reflected in tables and figures.
Results: The INEF working group was equipped with a work system to face the pandemic given the high vulnerability of patients with CKD. 66 people were evaluated, 83.3% with suggestive symptoms. Of these, 34 were admitted in the context of chronic kidney disease, 21 were referred to the temporary isolation center, 7 in relation to a transplant operation, and 4 workers for focus control. All the cases underwent a SARS COV2 polymerase chain reaction test and the result was negative.
Conclusions: In the INEF, strengthening the surveillance system against COVID 19 and working with high suspicion indexes in vulnerable populations, no related event occurred in the period.


REFERENCES

  1. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020; 368:1091. DOI: https://doi.org/10.1136/bmj.m1091

  2. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. PubMed PMID: 32091533

  3. Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020; 323(18):1775–6. DOI: https://doi.org/10.1001/jama.2020.4683

  4. Fonte Galindo L, García Menéndez G. SARS CoV-2 ¿el más letal coronavirus?. Rev Cubana Hig Epidemiol. 2020 [acceso: 19/1/2021]; 57(0):[aprox. 0 p.]. Disponible en: http://www.revepidemiologia.sld.cu/index.php/hie/article/view/437

  5. Ferreiro Fuentes, et al: Recomendaciones para el manejo de pacientes portadores de enfermedad renal frente a la epidemia de coronavirus (COVID- 19). Nefro Latinoam. 2020[acceso: 3/4/2020];17:1-6. Disponible en: https://www.revistarenal.org.ar/index.php/rndt/article/view./506

  6. Organización Mundial de la Salud. Ginebra, Suiza. Preguntas y respuestas sobre la enfermedad por coronavirus (COVID-19). OMS. c2020 [acceso: 28/1/2020]; [aprox. 25 p.]. Disponible en: https://www.who.int/es/emergencies/diseases/novel-coronavirus- 2019/advice-for-public/q-a-coronaviruses

  7. Protocolo de actuación nacional para la COVID-19 Versión 1.4. Ministerio de Salud Pública, Cuba. 2020:132. Disponible en: https://covid19cubadata.github.io/protocolos/protocolo-version-4.pdf

  8. Información y criterios para la priorización de pruebas diagnósticas del SARSCoV- 2 para dirigir las necesidades de adquisición por los sistemas de salud, 8 de abril del 2020. Washington, D.C., OPS. Disponible en: https://iris.paho.org/handle/10665.2/52148

  9. Kampf G. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. Journal of Hospital Infection. 2020; 104(3):246-51. DOI: https://doi.org/10.1016/j.jhin.2020.01.022

  10. Guanche Garcell H, González Valdés A, González Álvarez L. COVID-19 y el problema de los tiempos en las estrategias de control. Rev haban cienc méd [Internet]. 2020 [citado]; 19(Supl.):e3318. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3318

  11. Wang D, Hu B, Hu C. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-9. DOI: https://doi.org/10.1001/jama.2020.1585

  12. Hernández Rodríguez J. Aspectos clínicos relacionados con el Síndrome Respiratorio Agudo Severo (SARS-CoV-2). Revista Habanera de Ciencias Médicas. 2020[acceso: 22/6/2020];19(Supl.): e3279. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3279

  13. Coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK – seventh update. European Center for Disease Control and Prevention. 25 March 2020. Stockholm: ECDC. 2020:1-25. Disponible en: https://www.ecdc.europa.eu/sites/default/files/documents/RRA-seventhupdateOutbreak- of-coronavirus-disease-COVID-19.pdf

  14. Fanelli. Acute kidney injury in SARS-CoV-2 infected patients. Critical Care. 2020; 24:155. DOI: https://doi.org/10.1186/s13054-020-02872-z

  15. Zhen Li, Ming Wu, Jie Guo. Caution on Kidney Dysfunctions of 2019-nCoV Patients. MedRxiv preprint. DOI: https://doi.org/10.1101/2020.02.08.20021212

  16. Andreu Périz D, Hidalgo Blanco M, Moreno Arroyo C. Eventos infecciosos en pacientes en hemodiálisis. Enferm Nefrol. 2015 eneromarzo[ acceso:1/9/2016];18(1):54-6. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2254- 28842015000100008

  17. Fiterre Lancis I, Suárez Rubio C, Sarduy Chapis RL, Castillo Rodríguez B, Gutiérrez García F, Sabournin Castel N, Ivars Bolaños EV, et al. Factores de riesgo asociados con sepsis del acceso vascular de pacientes en hemodiálisis. Revista Habanera de Ciencias Médicas. 2018[acceso: 29/10/2020]; 17(2):335- 46. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/2137

  18. Lotfi B, Farshid S, Dadashzadeh N, Valizadeh R, Rahimi MM. Is Coronavirus Disease 2019 (COVID-19) Associated with Renal Involvement? A Review of Century Infection, Jundishapur J Microbiol. 2020;13(4): e102899. DOI: https://doi.org/10.5812/jjm.102899




2020     |     www.medigraphic.com